R&D

A cloud-based digital pathology platform has helped a CRO deliver more informed preclinical studies.  Proscia announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research.   Context  90% of drug candidates fail during clinical trials.1 This negatively impacts R&D efficiency, as measured by the number of new drugs approved relative […]

This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from Prilenia Therapeutics”. In the first article, Brad […]

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join the community.  The CoE aims to […]

A new partnership will bring together Microsoft’s computational services, cloud and artificial intelligence (AI) and Novo Nordisk’s drug discovery, development and data science capabilities. Through the agreement, Microsoft will provide AI technology, foundational science models and expertise and work alongside Novo Nordisk’s data scientists and domain experts to accelerate the company’s R&D. “The collaboration with […]

BioIVT has acquired XenoTech, a provider of products and services for preclinical testing that specialises in ADME, DMPK and DDI testing of potential drug candidates.  Through the acquisition, BioIVT aims to expand the portfolio of research models and services that are available to its clients to support their R&D function.   “XenoTech has a well-established and excellent reputation […]

Benchling has launched its first full set of capabilities for designing, modeling, and studying both natural and chemically modified RNA in a single solution. As the biopharmaceutical industry increases its focus on developing RNA therapeutics, the new RNA solution could help R&D organisations accelerate the delivery of drug candidates. Following the successful deployment of RNA […]

Merck has opened a new Launch and Technology Center for healthcare in Darmstadt, costing the company around €160 million. This is part of a planned investment of more than €1.5 billion at the global headquarters in Darmstadt by 2025. The Launch and Technology Center will bridge research and commercial production and will enable the company […]

Michael Henderson, MD, Chief Business Officer of BridgeBio Pharma, tells Lu Rahman about the company’s pursuit of transformative medicines to treat genetic diseases. BridgeBio’s mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers as quickly and safely as possible. “To do […]

AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Successful proposals will secure fully funded postdoctoral research positions. The challenge The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and postdoctoral researchers from across the […]

Listen to this article on the DDW Podcast: Dr Michael Hayden’s early encounters and experience with patients and families suffering from Huntington’s Disease has had a significant personal impact that shaped his career. As CEO of Prilenia Therapeutics, he tells Lu Rahman why he has dedicated his career to advancing research into this and other neurodegenerative […]